The Omega 3 market size will be worth approximately $17.6 billion per

Ottawa, Nov. 17, 2022 (GLOBE NEWSWIRE) — Precedence Research, recently announced a report on “Omega 3 market – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook and Forecast 2022-2030”.

Regional Scliches:

Due to the changing inclination of customers towards a nutritious diet including omega-3 components, APAC achieved the highest revenue in 2021. Eicosapentaenoic acid (EPA) along with oils DHA have their third market outside the United States in China. . In China, fortified foods and fish supplements are the main sources of omega-3s for consumers. Over the years, Japan has authorized a few foods for specific medical uses of omega-3 fatty acids.

Get the sample Copy report@

However, several Japanese companies have successfully applied for new medical benefit claims for these fatty acids thanks to new Japanese legislation. If the industry is becoming more active in backing up these claims, it also means there is a major shift to improve the environment for omega-3 supplements in the region.

Key points to remember:

  • The North American market was valued at 38.2% revenue share in 2021.
  • By application, the supplements and functional foods segment held a market share of 52.6% in 2021. However, the infant formula segment is poised to grow at the fastest CAGR from 2022 to 2030.
  • By source, the marine sources segment captured 83.4% revenue share in 2021.
  • By type, docosahexaenoic acid (DHA) held 63% revenue share in 2021.

Report Highlights:

  • A significant trend in the omega-3 industry is that customers are becoming more aware of health products. The acceptance of health and beauty products as extensions of the foods consumed by consumers is becoming more widespread among consumers.
  • Around the world, a new spectrum of nutritional items is emerging, ranging from functional and fortified foods to dietary supplements. This continuum includes dog food and grooming products for pet owners, essentially mirroring product selection for humans.
  • Over the past five years, the market has seen a dramatic increase in the use of omega-3 supplements due to growing evidence that they can reduce cognitive decline and prevent heart disease, anxiety, rheumatism and asthma.
  • Omega-3 fatty acids must come from the diet because they are needed and cannot be produced by the human body. This influences the expansion of the market all over the world. Moreover, pregnant women and nursing mothers prefer to use these supplements because docosahexaenoic acid (DHA) was extremely important throughout pregnancy and the first years of a baby’s life.
  • Additionally, DHA continues to be essential for newborn brain development. All of these contribute to the expansion of the global market for omega-3 products.

Ask here for more customization study @

Report scope

Report attributes Details
Market size in 2022 $9.02 billion
Revenue forecasts by 2030 $17.6 billion
CAGR 8.71% from 2022 to 2030
Year of reference 2021
forecast year 2022 to 2030
Key players Adisseo, ADM, ALGISYS LLC, BASF SE, Biosearch Life, Church & Dwight, Inc., BTSA Biotechnologias Aplicadas SL, Copeinca AS, Corpesca SA, DSM, Epion Brands, Farbest Brands, FF Skagen A/S, FMC Corporation, Colpex International , Golden Omega, Huatai Biopharm, Kinomega Biopharm Inc., Lonza Group, Marvesa Holding NV, Glanbia Plc, Nordic Naturals, NOW Foods, Omega Protein Corporation.

Market dynamics:


The threat of arrhythmia or heart problems, which could lead to the patient’s sudden death, is mitigated by omega-3 fatty acids. Plus, it helps lower cholesterol levels, heart rate, as well as the rate at which the arterial wall expands. Clients are increasingly choosing healthy alternatives, even as they view preventative services as an essential tool to help them adopt healthy behaviors. Omega 3s are becoming increasingly popular as they are excellent vitamins, sources of protein and minerals and can help in the treatment of diseases such as cancer, asthma and depression.


Market expansion, however, is limited by uneven fish catches and increased demand for salmon from these other sources of use. Fish consumption is becoming increasingly harmful due to rising levels of environmental metals and hazardous contaminants, which is expected to restrain the expansion of the segment. The company’s supply of raw materials is also expected to be impacted by tighter controls on fishing to conserve fish species.


Increase in customer fitness and health initiatives, in addition to increased use of omega-3 fatty acids in animal feeds and pharmaceuticals, are all driving the growth of the market. Growing public awareness of the health benefits of omega-3s is pushing market players to want to innovate.

On the other hand, the technique disperses strong oils in the segments and sub-compositions to improve surface adsorption. OmegaZero® nanotechnology dramatically reduces the surface area of ​​foul-smelling oil in contact with air by helping odoriferous oil to emulsify inside the stomach instead of producing a coating on the outside of acid gastric.


Omega-3s are produced from expensive and highly unstable fish and other marine oils. This factor complicates the growth of the omega-3 fatty acids sector. Fluctuating commodity prices hurt the omega-3 industry. The sharp rise in the prices of these basic resources is only a consequence of the increase in agricultural expenditure. Feed is an essential component of aquaculture, but keeping feed costs stable is expensive. Imported or purchased fish becomes much more expensive. Expansion of the business is further limited by rising labor, energy and electricity costs as well as restrictions on deep sea fishing. commodity prices are holding back the expansion of the industry.

Related Reports

Receive our latest press releases @

Recent Ddevelopments:

  • Croda International Plc and Genesis Biosciences established a global marketing and sales cooperation in January 2021. A specialty chemicals company called Croda Worldwide Plc uses cutting-edge research to create superior chemicals and services that improve lives . Through this new partnership, Croda has been able to expand its portfolio of safe and secure raw cleaning resources.
  • Moderna and Lonza formed a cooperation in June 2021 for the Dutch active pharmaceutical ingredient (API manufacturing of Moderna’s COVID-19 vaccine. An additional 300 million doses per year could be produced at Lonza’s plant in Geleen, Netherlands). Low, using a new drug ingredient assembly line that will complement the existing system.
  • Lonza will continue to work with a large pharma collaborator to deliver mass-produced monoclonal from July 2021. The addition of consideration for creating an antibody-drug combo for use in the treatment of hard-to- process will be complemented by a long-standing collaboration for mass shipments of monoclonal.
  • On April 20, 2021, KD Pharmaceuticals Group acquired the manufacturing tools of a Swiss-based marijuana producer. Through the acquisitions, KD Pharma now has technology to produce active pharmaceutical ingredients that rely on phytocannabinoids in addition to other botanical extracts.
  • Orkla Health acquired NutraQ in June 2021, but this action will open up intriguing new business opportunities for Orkla. Healthcare and direct-to-consumer sales are growing industries that will continue to improve core NutraQ concepts while exploring new avenues for these sales.
  • In August 2021, Corbion announced that it had acquired Granolife, a Mexican company based in Querétaro that supplies functional mixes to the country’s baking and fortification industries. About 60 employees work for Granolife in its manufacturing plant as well as applications inside the training center.

Market segmentation

By type

  • Docosahexaenoic acid (DHA)
  • Eicosapentaenoic acid (EPA)
  • Alpha-linolenic acid (ALA)

By origin

  • marine source
    • fish oil
    • Algae oil
    • krill oil
    • Others
  • plant origin
    • Walnut seeds
    • vegetable oils
    • Soy

By end use

  • Nutraceuticals and Supplements
  • Food and drinks
  • Medications
  • Personal care
  • Infant formula
  • Fish food
  • Others

By geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Immediate delivery available | Buy this Premium Research Report @

You can place an order or ask any questions, please feel free to contact at [email protected] | +1 9197 992 333

About Us

Precedence Research is a global market research and consulting organization. We provide an unparalleled nature of offering to our customers located all over the world across industry verticals. Precedence Research has expertise in providing in-depth market intelligence as well as market insights to our clients spread across various businesses. We are obligated to serve our diverse customer base in medical services, healthcare, innovation, next-generation technology, semiconductor, chemical, automotive, aerospace and defence, among the various companies present in the world.

For the latest update, follow us:

More Stories
Giant batteries, key to solar and wind power plans, get bank backing